Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer|Circulating Tumor DNA|Gene Abnormality
Interventions: DRUG: Control group|DRUG: Case group
Sponsor: Hunan Cancer Hospital